Uncategorized
VIDEO: BOULEVARD trial advances molecule for treatment of DME
VANCOUVER, British Columbia — At the American Society of Retina Specialists annual meeting, Rishi P. Singh, MD, discusses findings from the BOULEVARD trial, which he said validated the signal of RG7716 (Genentech/Roche) as a potential molecule for the treatment of diabetic macular edema and demonstrated the agent’s “superiority to currently available therapeutics” as well as potential increased durability over time.